Chilean pharmaceutical policy
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
The Chilean Pharmaceutical Policy was an attempt in the 1960s and 1970s to introduce a rational national pharmaceuticals policy. Chile was perhaps the first country in the world to introduce the concept of a limited number of essential drugs.
In 1965 the government of President Eduardo Frei took measures to rationalise drug supply and use and in 1967, a national formulary with a limited list of drugs came into being. In 1970, Dr Salvador Allende was elected to power and rationalisation of the pharmaceutical supply system continued.
The next step was to organise centralised bulk procurement. The first international tender for raw materials was called in 1971. However, the pharmaceutical industry struck back: in the three months following the call for tender, widely used drugs, including analgesics and antibiotics, disappeared from the market. The manufacturers had cut their production. They agreed to replenish the market within one week only if the international tenders were called off.
In 1972, the government was forced to succumb and called off the tenders. In 1973, the government of Allende was toppled and the first essential drug programme hitherto known was dead.
References
See also
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
